REAL Canadian Breast Cancer Alliance is pleased to announce the appointment of Dr. Mita Manna as the new Chair of the organization. Dr. Manna, a highly respected Hematologist and Medical Oncologist at the Saskatchewan Cancer Centre and soon-to-be Associate Professor at the University of Saskatchewan’s Department of Oncology (effective April 2025), brings a wealth of experience in breast cancer research, patient advocacy, and clinical leadership to this pivotal role.

Founded in 2023, REAL (Research Excellence and Active Leadership) Canadian Breast Cancer Alliance unites leading clinicians across Canada in a shared mission to advance breast cancer care through evidence-based research and to promote equity in access to cutting-edge treatments.

“I am deeply honoured to step into this leadership role and to build on the solid foundation established by Dr. Jan-Willem Henning,” said Dr. Manna. “Dr. Henning’s visionary leadership has created an essential platform for collaboration among Canada’s top thought leaders in breast oncology. As Chair, I’m committed to ensuring that research continues to translate into accessible, life-saving care for patients nationwide.”

Dr. Jan-Willem Henning, Immediate Past Chair & Founder of REAL Canadian Breast Cancer Alliance, expressed his confidence in Dr. Manna’s leadership.  “Dr. Manna’s unwavering commitment to research, patient care, and advocacy will drive REAL’s future impact. Her leadership is vital to ensuring that all breast cancer patients in Canada benefit from the latest advancements in research.”

Kimberly Carson, CEO of Breast Cancer Canada, also welcomed Dr. Manna’s appointment: “Dr. Manna embodies an exceptional dedication to advancing research and improving patient outcomes. We are excited to work alongside her as we continue to strive for a future where every Canadian patient has access to the highest standard of breast cancer care.”

Under Dr. Manna’s leadership, REAL Canadian Breast Cancer Alliance will continue to champion innovative research, advocate for equitable access to the latest treatments, and foster collaboration among healthcare professionals, researchers, and patients to accelerate advancements in breast cancer care nationwide.

REAL Canadian Breast Cancer Alliance plays a key role in shaping national care standards, releasing annual clinical consensus recommendations that reflect the latest research outcomes and clinical trial data. These recommendations ensure comprehensive, evidence-based management for breast cancer patients.

The following national consensus recommendations are set to be completed and released later this year:

• Treatment Management of HR+ Early Stage Breast Cancer

• Treatment Management of HR+ Metastatic Breast Cancer

• Treatment Management of Triple Negative Breast Cancer

• Treatment Management Using Molecular Diagnostics and Markers

For more information on REAL Canadian Breast Cancer Alliance, its mission, and full membership, please visit realalliance.ca.